Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

High density lipoprotein deficiency with xanthomas. A defect in reverse cholesterol transport caused by a point mutation in the apolipoprotein A-I gene.
K J Lackner, … , G Nowicka, G Schmitz
K J Lackner, … , G Nowicka, G Schmitz
Published November 1, 1993
Citation Information: J Clin Invest. 1993;92(5):2262-2273. https://doi.org/10.1172/JCI116830.
View: Text | PDF
Research Article

High density lipoprotein deficiency with xanthomas. A defect in reverse cholesterol transport caused by a point mutation in the apolipoprotein A-I gene.

  • Text
  • PDF
Abstract

A 7-yr-old girl with high density lipoprotein (HDL) deficiency and xanthomas has been identified in a Turkish kindred with repetitive consanguinity. She has severely reduced HDL-cholesterol and no apolipoprotein (apo) A-I. ApoA-II is reduced, whereas apoA-IV and apoC-III are normal. ApoB and low density lipoprotein (LDL)-cholesterol are increased. This is reflected in hypercholesterolemia. VLDL and IDL particles are low, and serum triglycerides are normal. The genetic defect could be identified as a base insertion into the third exon of the apoA-I gene. This leads to a nonsense peptide sequence beginning at amino acid 5 of the mature plasma protein and early termination of translation. The patient is homozygous for this mutation. Pedigree analysis indicated an autosomal dominant inheritance with no evidence of another genetic defect of lipoprotein metabolism in the kindred. In HDL deficiency, HDL binding to leukocytes was increased compared to normal. In the postprandial state, binding of labeled HDL3 to leukocytes is unchanged. This is in contrast to results with postprandially isolated leukocytes from controls or Tangier patients, which have a reduced binding capacity for HDL3. These results indicate that postprandial HDL precursors may compete the binding of labeled HDL3. The metabolic consequences of HDL deficiency were analyzed. There is only a small number of HDL-like particles containing apoA-II, apoA-IV, apoE, and lecithin/cholesteryl acyl transferase. The C-apolipoproteins were normal in the proband. Due to the lack of HDL they can only associate with apoB-containing particles, where they may interfere with cellular uptake. Thus, pure apoA-I deficiency leads to a complex metabolic derangement.

Authors

K J Lackner, H Dieplinger, G Nowicka, G Schmitz

×

Total citations by year

Year: 2022 2018 2012 2010 2008 2004 2003 2002 2000 1999 1998 1997 1996 1995 1994 Total
Citations: 1 1 1 3 1 1 4 1 1 1 4 4 6 7 2 38
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (38)

Title and authors Publication Year
Lack of ApoA-I in ApoEKO Mice Causes Skin Xanthomas, Worsening of Inflammation, and Increased Coronary Atherosclerosis in the Absence of Hyperlipidemia.
Busnelli M, Manzini S, Colombo A, Franchi E, Bonacina F, Chiara M, Arnaboldi F, Donetti E, Ambrogi F, Oleari R, Lettieri A, Horner D, Scanziani E, Norata GD, Chiesa G
Arteriosclerosis, thrombosis, and vascular biology 2022
Identification of the first Tangier disease patient in Lebanon carrying a new pathogenic variant in ABCA1
PE Khoury, P Couvert, S Elbitar, Y Ghaleb, Y Abou-Khalil, Y Azar, C Ayoub, A Superville, M Guérin, JP Rabès, M Varret, C Boileau, S Jambart, P Giral, A Carrié, WL Goff, M Abifadel
Journal of Clinical Lipidology 2018
Genetic control of high density lipoprotein-cholesterol in AcB/BcA recombinant congenic strains of mice
SA Wiltshire, E Diez, Q Miao, MP Dubé, M Gagné, O Paquette, RG Lafrenière, M Ndao, LW Castellani, E Skamene, SM Vidal, A Fortin
Physiological genomics 2012
Complete Apo AI Deficiency in an Iraqi Mandaean Family: Case studies and review of the literature
A Al-Sarraf, K Al-Ghofaili, DR Sullivan, KM Wasan, R Hegele, J Frohlich
Journal of Clinical Lipidology 2010
The HDL Handbook
NJ Hime
The HDL Handbook 2010
Atlas of Atherosclerosis and Metabolic Syndrome
SM Grundy
2010
A novel mutation of the apolipoprotein A-I gene in a family with familial combined hyperlipidemia
L Pisciotta, T Fasano, L Calabresi, A Bellocchio, R Fresa, C Borrini, S Calandra, S Bertolini
Atherosclerosis 2008
Characterization of lecithin:cholesterol acyltransferase expressed in a human lung cell line
SB Lane, KT Tchedre, MP Nair, AE Thigpen, AG Lacko
Protein Expression and Purification 2004
High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions
P Barter, J Kastelein, A Nunn, R Hobbs
Atherosclerosis 2003
Recurrent mutations of the apolipoprotein A-I gene in three kindreds with severe HDL deficiency
L Pisciotta, R Miccoli, A Cantafora, L Calabresi, P Tarugi, P Alessandrini, GB Bon, G Franceschini, C Cortese, S Calandra, S Bertolini
Atherosclerosis 2003
Atlas of Atherosclerosis
PW Wilson
2003
Biochemie und Pathobiochemie
G Löffler, PE Petrides
2003
Quantitative trait locus mapping of genes that regulate HDL cholesterol in SM/J and NZB/B1NJ inbred mice
WA Pitman, R Korstanje, GA Churchill, E Nicodeme, JJ Albers, MC Cheung, MA Staton, SS Sampson, S Harris, B Paigen
Physiological genomics 2002
Progressive familial intrahepatic cholestasis: partial biliary diversion normalizes serum lipids and improves growth in noncirrhotic patients
M Melter, B Rodeck, R Kardorff, PF Hoyer, C Petersen, A Ballauff, J Brodehl
The American Journal of Gastroenterology 2000
Compound Heterozygosity for an Apolipoprotein A1 Gene Promoter Mutation and a Structural Nonsense Mutation With Apolipoprotein A1 Deficiency
A Matsunaga, J Sasaki, H Han, W Huang, M Kugi, T Koga, S Ichiki, T Shinkawa, K Arakawa
Arteriosclerosis, thrombosis, and vascular biology 1999
Characterization of two HDL subfractions and LpA-I, LpA-I:A-II distribution profiles and clinical characteristics of hyperalphalipoproteinemic subjects without cholesterol ester transfer protein deficiency
D Sich, Y Saı̈di, P Giral, L Lagrost, J Dallongeville, MC Federspiel, C Cherfils, A Raisonnier, G Turpin, I Beucler
Atherosclerosis 1998
Continuous free-flow electrophoresis
L Křivánková, P Boček
Electrophoresis 1998
Apolipoprotein A-I Zavalla (Leu 159 →Pro): HDL Cholesterol Deficiency in a Kindred Associated With Premature Coronary Artery Disease
M Miller, D Aiello, H Pritchard, G Friel, K Zeller
Arteriosclerosis, thrombosis, and vascular biology 1998
A Novel Homozygous Missense Mutation in the Apo A-I Gene With Apo A-I Deficiency
W Huang, J Sasaki, A Matsunaga, H Nanimatsu, K Moriyama, H Han, M Kugi, T Koga, K Yamaguchi, K Arakawa
Arteriosclerosis, thrombosis, and vascular biology 1998
Analytical capillary isotachophoresis of human serum lipoproteins
G Schmitz, C Möllers, V Richter
Electrophoresis 1997
Apolipoprotein A-I Fin: Dominantly Inherited Hypoalphalipoproteinemia Due to a Single Base Substitution in the Apolipoprotein A-I Gene
HE Miettinen, H Gylling, TA Miettinen, J Viikari, L Paulin, K Kontula
Arteriosclerosis, thrombosis, and vascular biology 1997
Apolipoprotein A-I FIN (Leu159→Arg) Mutation Affects Lecithin: Cholesterol Acyltransferase Activation and Subclass Distribution of HDL but Not Cholesterol Efflux From Fibroblasts
HE Miettinen, M Jauhiainen, H Gylling, S Ehnholm, A Palomäki, TA Miettinen, K Kontula
Arteriosclerosis, thrombosis, and vascular biology 1997
Heterozygosity for apolipoprotein A-I(R160L)Oslo is associated with low levels of high density lipoprotein cholesterol and HDL-subclass LpA-I/A-II but normal levels of HDL-subclass LpA-I
TP Leren, KS Bakken, U Daum, L Ose, K Berg, G Assmann, A von Eckardstein
Journal of lipid research 1997
Retinopathy and Neuropathy Associated With Complete Apolipoprotein A-l Deficiency
DS Ng, PW OConnor, CB Mortimer, LA Leiter, PW Connelly, RA Hegele
The American Journal of the Medical Sciences 1996
Retinopathy and Neuropathy Associated With Complete Apolipoprotein A-I Deficiency:
DS Ng, PW O'Connor, CB Mortimer, LA Leiter, PW Connelly, RA Hegele
The American Journal of the Medical Sciences 1996
Compound Heterozygosity for a Structural Apolipoprotein A-I Variant, Apo A-I(L141R) Pisa , and an Apolipoprotein A-I Null Allele in Patients With Absence of HDL Cholesterol, Corneal Opacifications, and Coronary Heart Disease
R Miccoli, A Bertolotto, R Navalesi, L Odoguardi, A Boni, J Wessling, H Funke, H Wiebusch, A von Eckardstein, G Assmann
Circulation 1996
A Cysteine-Containing Truncated Apo A-I Variant Associated With HDL Deficiency
K Moriyama, J Sasaki, Y Takada, A Matsunaga, J Fukui, JJ Albers, K Arakawa
Arteriosclerosis, thrombosis, and vascular biology 1996
Peripheral Blood Mononuclear Phagocyte Subpopulations as Cellular Markers in Hypercholesterolemia
G Rothe, H Gabriel, E Kovacs, J Klucken, J Stöhr, W Kindermann, G Schmitz
Arteriosclerosis, thrombosis, and vascular biology 1996
Molecular Reviews in Cardiovascular Medicine
K Lindpaintner, D Ganten
1996
Is reverse cholesterol transport a misnomer for suggesting its role in the prevention of atheroma formation?
EC Quintão
Atherosclerosis 1995
Structural models of human apolipoprotein A-I
C Brouillette
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 1995
The low down on lipoprotein lipase
H Funke, G Assmann
Nature Genetics 1995
Reverse Cholesterol Transport in Plasma of Patients With Different Forms of Familial HDL Deficiency
A von Eckardstein, Y Huang, S Wu, H Funke, G Noseda, G Assmann
Arteriosclerosis, thrombosis, and vascular biology 1995
Apolipoprotein A-I Deficiency: Biochemical and Metabolic Characteristics
DS Ng, C Vezina, TS Wolever, A Kuksis, RA Hegele, PW Connelly
Arteriosclerosis, thrombosis, and vascular biology 1995
A New Case of ApoA-I Deficiency Showing Codon 8 Nonsense Mutation of the ApoA-I Gene Without Evidence of Coronary Heart Disease
K Takata, K Saku, T Ohta, M Takata, H Bai, S Jimi, R Liu, H Sato, G Kajiyama, K Arakawa
Arteriosclerosis, thrombosis, and vascular biology 1995
Severe Familial HDL Deficiency in French-Canadian Kindreds: Clinical, Biochemical, and Molecular Characterization
M Marcil, B Boucher, L Krimbou, BC Solymoss, J Davignon, J Frohlich, J Genest
Arteriosclerosis, thrombosis, and vascular biology 1995
Recent concepts of lipoprotein pathophysiology
G Schonfeld
Atherosclerosis 1994
A nonsense mutation in the apolipoprotein A-I gene is associated with high-density lipoprotein deficiency and periorbital xanthelasmas
R Römling, A von Eckardstein, H Funke, C Motti, GC Fragiacomo, G Noseda, G Assmann
Arteriosclerosis Thrombosis and Vascular Biology 1994

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts